Köse F - Search Results

1

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Sümbül AT, Dişel U, Sezgin N, Sezer A, Köse F, Beşen AA, Sümbül Z, Abalı H, Özyılkan Ö. Sümbül AT, et al. Among authors: kose f. Med Sci Monit. 2014 Mar 15;20:428-33. doi: 10.12659/MSM.889945. Med Sci Monit. 2014. PMID: 24632679 Free PMC article.

2

Squamous cell carcinoma of the renal pelvis.

Kose F, Bal N, Ozyilkan O. Kose F, et al. Med Oncol. 2009;26(1):103-4. doi: 10.1007/s12032-008-9089-4. Epub 2008 Aug 1. Med Oncol. 2009. PMID: 18670910 No abstract available.

3

Little dose, huge toxicity: profound hematological toxicity of intrathecal methotrexate.

Kose F, Abali H, Sezer A, Mertsoylu H, Disel U, Ozyilkan O. Kose F, et al. Leuk Lymphoma. 2009 Feb;50(2):282-3. doi: 10.1080/10428190802603169. Leuk Lymphoma. 2009. PMID: 19197737 No abstract available.

4

Primary renal lymphoma: report of four cases.

Kose F, Sakalli H, Mertsoylu H, Sezer A, Kocer E, Tokmak N, Kilinc F, Ozyilkan O. Kose F, et al. Onkologie. 2009 Apr;32(4):200-2. doi: 10.1159/000203331. Epub 2009 Mar 13. Onkologie. 2009. PMID: 19372716

5

Immediate or delayed docetaxel: does progression-free survival really reflect two strategies?

Abali H, Disel U, Köse F, Sezer A, Mertsoylu H. Abali H, et al. Among authors: kose f. J Clin Oncol. 2009 Jun 10;27(17):2889; author reply 2889. doi: 10.1200/JCO.2009.22.3305. Epub 2009 Apr 27. J Clin Oncol. 2009. PMID: 19398567 No abstract available.

6

The prevalence of depression in patients with cancer in Jordan.

Kose F, Abali H, Besen A, Disel U, Hayran M. Kose F, et al. Support Care Cancer. 2010 Jun;18(6):657-8. doi: 10.1007/s00520-010-0842-9. Epub 2010 Apr 8. Support Care Cancer. 2010. PMID: 20376503 No abstract available.

7

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Dişel U, Oztuzcu S, Beşen AA, Karadeniz C, Köse F, Sümbül AT, Sezer A, Nursal GN, Abalı H, Ozyılkan O. Dişel U, et al. Among authors: kose f. Lung Cancer. 2011 Jan;71(1):109-12. doi: 10.1016/j.lungcan.2010.09.011. Lung Cancer. 2011. PMID: 20970876

8

Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.

Kose F, Oguzkurt L, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Mertsoylu H, Ozyilkan O. Kose F, et al. Eur J Radiol. 2012 Aug;81(8):1724-7. doi: 10.1016/j.ejrad.2011.04.056. Epub 2011 May 18. Eur J Radiol. 2012. PMID: 21596502

9

Severe systemic vasoconstriction starting with acute limb ischemia leading to death in a patient with well-differentiated pulmonary neuroendocrine carcinoma: a new paraneoplastic syndrome?

Karadeniz C, Köse F, Abali H, Sümbül AT, Oğuzkurt L, Karabacak T, Oberg K. Karadeniz C, et al. Among authors: kose f. Acta Oncol. 2012 Jan;51(1):124-7. doi: 10.3109/0284186X.2011.602115. Epub 2011 Aug 22. Acta Oncol. 2012. PMID: 21859354 No abstract available.

10

Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.

Kose F, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Altundag O, Ozyilkan O. Kose F, et al. Asian Pac J Cancer Prev. 2011;12(5):1185-8. Asian Pac J Cancer Prev. 2011. PMID: 21875263 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters